NHIQ vs. BMRA, SJ, LUCD, LTRPA, ADEX, GDTC, FBRX, LSTA, NEPH, and RNXT
Should you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Biomerica (BMRA), Scienjoy (SJ), Lucid Diagnostics (LUCD), Liberty TripAdvisor (LTRPA), Adit EdTech Acquisition (ADEX), CytoMed Therapeutics (GDTC), Forte Biosciences (FBRX), Lisata Therapeutics (LSTA), Nephros (NEPH), and RenovoRx (RNXT).
NantHealth (NASDAQ:NHIQ) and Biomerica (NASDAQ:BMRA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability.
22.3% of Biomerica shares are owned by institutional investors. 61.3% of NantHealth shares are owned by company insiders. Comparatively, 13.5% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
NantHealth has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Biomerica has a beta of -0.92, meaning that its stock price is 192% less volatile than the S&P 500.
Biomerica received 137 more outperform votes than NantHealth when rated by MarketBeat users.
In the previous week, Biomerica had 3 more articles in the media than NantHealth. MarketBeat recorded 3 mentions for Biomerica and 0 mentions for NantHealth. Biomerica's average media sentiment score of 0.92 beat NantHealth's score of 0.00 indicating that Biomerica is being referred to more favorably in the news media.
Biomerica has lower revenue, but higher earnings than NantHealth.
NantHealth has a net margin of -109.49% compared to Biomerica's net margin of -117.46%. NantHealth's return on equity of 0.00% beat Biomerica's return on equity.
Summary
NantHealth and Biomerica tied by winning 6 of the 12 factors compared between the two stocks.
Get NantHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for NHIQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NHIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NantHealth Competitors List
Related Companies and Tools
